EssilorLuxottica SA header image

EssilorLuxottica SA

EL

Equity

ISIN FR0000121667 / Valor 497537

Euronext - Euronext Paris (2026-02-20)
EUR 238.20+2.23%

EssilorLuxottica SA
UMushroom community rating:

star star star star star
3.75 2 votes No rating yet
NegativeNeutralPositive

About company

EssilorLuxottica SA is a global leader in the design, manufacture, and distribution of ophthalmic lenses, optical equipment, and prescription glasses and sunglasses. The company represents a merger of two industry giants, Essilor and Luxottica, combining their strengths in lens technology and eyewear brands. EssilorLuxottica's portfolio includes some of the most iconic names in the eyewear industry, such as Ray-Ban, Persol, and Oakley, alongside optical retailers like Salmoiraghi & Viganò and GrandVision. The company's history is rich, with roots tracing back to the 19th century, showcasing a long-standing tradition in the eyecare and eyewear sector. Through its comprehensive approach that covers every aspect of the eyewear experience—from innovation and design to production and distribution—EssilorLuxottica has established itself as a key player in the global market, dedicated to advancing the eyecare and eyewear industry for consumers around the world.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-18.6%1Y
35.8%3Y
78.8%5Y

Performance

29.0%1Y
23.0%3Y
24.5%5Y

Volatility

Market cap

129497 M

Market cap (USD)

Daily traded volume (Shares)

1,040,773

Daily traded volume (Shares)

1 day high/low

235.2 / 231.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.75

2 votes
Performance:
starstarstarstarstar
3.75
Innovation:
starstarstarstarstar
4.38
Society:
starstarstarstarstar
3.13
Nature:
starstarstarstarstar
2.38
Hugo Raffard
United Kingdom, 06 Nov 2025
star star star star star
mid firm
Matheo Mesny
United Kingdom, 21 Oct 2025
star star star star star
EssilorLuxottica is a defensible, well-positioned business in eyewear with a large market and decent growth pathways, making it a potentially reliable long-term holding, but don’t assume it’s a bargain and expect growth to be moderate rather than runaway.

EQUITIES OF THE SAME SECTOR

CRISPR Therapeutics Ltd
CRISPR Therapeutics Ltd CRISPR Therapeutics Ltd Valor: 33408113
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.16%USD 53.46
Merit Medical Systems Inc
Merit Medical Systems Inc Merit Medical Systems Inc Valor: 951136
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 82.21
Lantheus Holdings Inc
Lantheus Holdings Inc Lantheus Holdings Inc Valor: 24784644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.94%USD 73.87
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%USD 63.59
Interparfums Inc
Interparfums Inc Interparfums Inc Valor: 833467
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.23%USD 103.41
Progyny Inc
Progyny Inc Progyny Inc Valor: 50342281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%USD 20.98
AMEDISYS Inc
AMEDISYS Inc AMEDISYS Inc Valor: 399513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 100.99
LivaNova PLC
LivaNova PLC LivaNova PLC Valor: 28726218
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.78%USD 68.42
InMode Ltd.
InMode Ltd. InMode Ltd. Valor: 49023508
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%USD 15.22
Revance Therapeutics Inc
Revance Therapeutics Inc Revance Therapeutics Inc Valor: 23239569
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 3.65